Douglas Flora, Executive Medical Director of Yung Family Cancer Center at St. Elizabeth Healthcare, President-Elect of the Association of Cancer Care Centers, shared a post on LinkedIn:
”Episode 114 of AI and Healthcare is out: Navigating the predictive revolution in cancer care with Eric Lefkofsky.
‘The future is already here, it is just not evenly distributed.’ William Gibson
With the release of Episode 114, we have now reached over 87,000 subscribers and nearly 5 million downloads. We are incredibly grateful to each of you for listening, sharing, and helping us build this cool community.
Please consider joining us for ongoing conversations shaping the future of cancer care.
Add/follow TensorBlack on here for more insights into oncology innovation or subscribe to the podcast below as we continue to explore the intersection of AI, precision medicine, and clinical transformation.
Dr. Sanjay Juneja and I sat down with a special guest for this week’s episode, Eric Lefkofsky. While many know Eric as a serial entrepreneur and the co-founder of global tech successes like Groupon, Echo Global Logistics, and Lightbank, his focus shifted in 2015 toward a deeply personal mission. As the Founder and CEO of Tempus AI, he has built a technology company designed to battle cancer by leveraging artificial intelligence and a massive library of clinical and molecular data to advance precision medicine.
In this episode, we explore how AI, real-world data, genomic sequencing, and emerging technologies like organoids are reshaping oncology. From reducing diagnostic errors to matching patients with more effective therapies, these tools are transforming how clinicians make decisions and how researchers develop the next generation of treatments.
The conversation examines why healthcare adoption has lagged behind technological progress, the growing role of patient-driven intelligence, and how connected data might help eliminate thousands of preventable cancer deaths each year. Eric shares his vision for clinical decision support, drug development, and the future relationship between physicians and intelligent systems. Ultimately, this integration is about utilizing technology to replace the mundane with the humane in our clinics.
Thank you, Eric-fantastic stuff. We appreciate you joining us. Guys, go to the comments and leave me some names of future guests you’d like us to invite to the podcast.”
Other articles featuring Douglas Flora on OncoDaily.